LUMOS PHARMA, INC. Quarterly Stockholders' Equity Attributable to Parent in USD from Q4 2010 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
-
Summary
-
Lumos Pharma, Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2010 to Q3 2024.
- Lumos Pharma, Inc. Stockholders' Equity Attributable to Parent for the quarter ending September 30, 2024 was $4.91M, a 86.2% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)